Futility Rules for Telaprevir Combination Treatment for Patients With Hepatitis C Virus Infection

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 2, 2013, Pages 193-195

  Adda, Nathalie ^a   Bartels, Doug J ^a   Gritz, Linda ^a   Kieffer, Tara L ^a   Tomaka, Frank ^b   Bengtsson, Leif ^a   Luo, Don ^b   Jacobson, Ira M ^c   Kauffman, Robert S ^a   Picchio, Gaston ^b  

^a VERTEX PHARMACEUTICALS   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Chronic; Hepatitis; ; Inhibitor; ; Protease; SVR

Indexed keywords

PEGINTERFERON; RIBAVIRIN; TELAPREVIR; VIRUS RNA;

ARTICLE; DRUG EXPOSURE; HEPATITIS B; HEPATITIS C; HUMAN; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ANTIVIRAL AGENTS; CLINICAL TRIALS, PHASE III AS TOPIC; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MEDICAL FUTILITY; OLIGOPEPTIDES; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; VIRAL LOAD;

EID: 84872383252     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.10.045     Document Type: Article

References (8)

1. Jacobson I.M., McHutchison J.G., Dusheiko G., et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011, 364:2405-2416.
2. Zeuzem S., Andreone P., Pol S., et al. Telaprevir for retreatment of HCV infection. N Engl J Med 2011, 364:2417-2428.
3. McHutchison J.G., Everson G.T., Gordon S.C., et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med 2009, 360:1827-1838. [Erratum appears in: N Engl J Med 2009;361:1516].
4. McHutchison J.G., Manns M.P., Muir A.J., et al. Telaprevir for previously treated chronic HCV infection. N Engl J Med 2010, 362:1292-1303. [Erratum appears in: N Engl J Med 2010;362:1647].
5. Hézode C., Forestier N., Dusheiko G., et al. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection. N Engl J Med 2009, 360:1839-1850.
6. Sherman K.E., Flamm S.L., Afdhal N.H., et al. Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med 2011, 365:1014-1024. [Erratum appears in: N Engl J Med 2011;365:1551].
7. Cambridge M.A. Incivek™ [US prescribing information] 2012, Vertex Pharmaceuticals Incorporated, Cambridge, MA.
8. ® [US prescribing information] 2011, Roche-Genentech, South San Francisco, CA.